DI FEDERICO, ALESSANDRO

DI FEDERICO, ALESSANDRO  

Borsisti  

Mostra records
Risultati 1 - 20 di 24 (tempo di esecuzione: 0.028 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Acute kidney injury as a possible immune-related adverse event associated with sustained complete response to BRAF and MEK inhibitors in advanced, V600E-mutated melanoma Di Federico A.; Filippini D.M.; Sperandi F.; Ardizzoni A.; Melotti B. 2021-01-01 EUROPEAN JOURNAL OF CANCER - 1.01 Articolo in rivista -
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma Lamberti G.; Andrini E.; Sisi M.; Rizzo A.; Parisi C.; Di Federico A.; Gelsomino F.; Ardizzoni A. 2020-01-01 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - 1.01 Articolo in rivista -
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience Dall'Olio F.G.; Conci N.; Rossi G.; Fiorentino M.; De Giglio A.; Grilli G.; Altimari A.; Gruppion...i E.; Filippini D.M.; Di Federico A.; Nuvola G.; Ardizzoni A. 2020-01-01 LUNG CANCER - 1.01 Articolo in rivista -
Critical diagnostic delay associated with unusual presentation of hepatocellular carcinoma (Hcc) with orbital metastases: A case report Filippini D.M.; Di Federico A.; Lenzi B.; Nobili E.; Brocchi S.; Malvi D.; Brandi G. 2021-01-01 ANNALS OF PALLIATIVE MEDICINE - 1.01 Articolo in rivista -
Dual immune checkpoint blockade in hepatocellular carcinoma: where do we stand? Riccardo Carloni, Alessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, Alessandro Di Federico, An...drea Palloni, Mariacristina Di Marco, Gennaro Gadaleta-Caldarola, Giovanni Brandi 2022-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
The EGFR exon 19 mutant L747-A750>P exhibits distinct sensitivity to tyrosine kinase inhibitors in lung adenocarcinoma—letter Di Federico A.; Filippini D.M.; Dall'Olio F.G.; Conci N.; Minari R.; Tiseo M.; Ardizzoni A. 2020-01-01 CLINICAL CANCER RESEARCH - 1.01 Articolo in rivista -
FGFR inhibitors in elderly patients with advanced biliary tract cancer: an unsolved issue Rizzo A.; Ricci A.D.; Frega G.; Di Federico A.; Brandi G. 2021-01-01 EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY - 1.01 Articolo in rivista -
Hacking pancreatic cancer: Present and future of personalized medicine Di Federico A.; Tateo V.; Parisi C.; Formica F.; Carloni R.; Frega G.; Rizzo A.; Ricci D.; Di Mar...co M.; Palloni A.; Brandi G. 2021-01-01 PHARMACEUTICALS - 1.01 Articolo in rivista -
Hacking pancreatic cancer: Present and future of personalized medicine Di Federico A.; Tateo V.; Parisi C.; Formica F.; Carloni R.; Frega G.; Rizzo A.; Ricci D.; Di Mar...co M.; Palloni A.; Brandi G. 2021-01-01 PHARMACEUTICALS - 1.01 Articolo in rivista Hacking Pancreatic.pdf
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible? Di Federico A.; Nuvola G.; Sisi M.; Lenzi B.; Nobili E.; Campana D. 2020-01-01 ANTI-CANCER DRUGS - 1.01 Articolo in rivista -
Immune-based combinations for metastatic triple negative breast cancer in clinical trials: current knowledge and therapeutic prospects Rizzo A.; Ricci A.D.; Lanotte L.; Lombardi L.; Di Federico A.; Brandi G.; Gadaleta-Caldarola G. 2021-01-01 EXPERT OPINION ON INVESTIGATIONAL DRUGS - 1.01 Articolo in rivista -
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes Di Federico A.; Mosca M.; Pagani R.; Carloni R.; Frega G.; De Giglio A.; Rizzo A.; Ricci D.; Tavo...lari S.; Di Marco M.; Palloni A.; Brandi G. 2022-01-01 CANCERS - 1.01 Articolo in rivista -
Intensive follow-up program and oncological outcomes of 278 biliary tract cancer patients after curative intent surgery: A single-center retrospective experience Rizzo, A.; Frega, G.; Palloni, A.; Piemontese, A.; Di Federico, A.; Ricci, A.; Carloni, R.; Fabbr...i, F.; Novelli, M.; Tavolari, S.; Di Marco, M.; Ravaioli, M.; Brandi, G. 2021-01-01 ANNALS OF ONCOLOGY - 1.01 Articolo in rivista -
Nivolumab: an investigational agent for the treatment of biliary tract cancer Di Federico A.; Rizzo A.; Ricci A.D.; Frega G.; Palloni A.; Tavolari S.; Brandi G. 2021-01-01 EXPERT OPINION ON INVESTIGATIONAL DRUGS - 1.01 Articolo in rivista -
Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report Gelsomino F.; Di Federico A.; Filippini D.M.; Dall'Olio F.G.; Lamberti G.; Sperandi F.; Balacchi ...C.; Brocchi S.; Ardizzoni A. 2020-01-01 CLINICAL LUNG CANCER - 1.01 Articolo in rivista -
Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report Mariacristina Di Marco, Riccardo Carloni, Stefania De Lorenzo, Cristina Mosconi, Andrea Palloni, ...Elisa Grassi, Daria Maria Filippini, Angela Dalia Ricci, Alessandro Rizzo, Alessandro Di Federico, Donatella Santini, Daniela Turchetti, Claudio Ricci, Carlo Ingaldi, Laura Alberici, Francesco Minni, Rita Golfieri, Giovanni Brandi, Riccardo Casadei 2020-01-01 WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY - 1.01 Articolo in rivista -
PD-(L)1 inhibitors as single-agent or in combination with chemotherapy for advanced, PD-L1-high non-small cell lung cancer: a meta-analysis Di Federico A.; De Giglio A.; Nuvola G.; Deiana C.; Conci N.; Gelsomino F.; Ardizzoni A. 2021-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
PD-1/PD-L1 inhibitor monotherapy or in combination with chemotherapy as upfront treatment for advanced NSCLC with PD-L1 expression ≥ 50%: Selecting the best strategy Di Federico A.; De Giglio A.; Parisi C.; Gelsomino F.; Ardizzoni A. 2021-01-01 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - 1.01 Articolo in rivista -
The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma Brandi G.; Di Federico A.; Rizzo A.; De Lorenzo S.; Vasuri F.; Brocchi S.; Golfieri R.; Morelli M....C.; Frega G.; Palloni A. 2022-01-01 ANTI-CANCER DRUGS - 1.01 Articolo in rivista -
Prognostic relevance of pleural invasion for resected NSCLC patients undergoing adjuvant treatments: A propensity score-matched analysis of SEER database De Giglio A.; Di Federico A.; Gelsomino F.; Ardizzoni A. 2021-01-01 LUNG CANCER - 1.01 Articolo in rivista -